Research & Reference

Understand the transaction. Then interrogate the evidence.

Everything here exists to make one decision better informed: whether, when and how to sell – and, for an acquirer, whether, what and how to buy. Most of it was written from the seller’s chair, which is exactly why a buyer should read it: the chapters on buyers, valuation, diligence and integration describe the table you will be sitting at, and the buy-side mandate describes our side of it. Start with the question you actually have.

Ten minutes for the transaction, an hour for the decisions, eight chapters for the machinery.

Our research

Why different buyers value the same company differently.

Verify us

How we know what we know.

Every material figure on this site says where it came from, what it measures, and what it does not prove – and the five figures we publish about ourselves are defined once, in the terms they are counted in. Sources & evidence →

How we publish

Three kinds of writing, kept distinct.

The ReferenceHow the transaction works. Revised whenever a cited source changes.
Original researchFindings from our own data, with the method and the sample stated.
Decision notesPractitioner judgment on questions owners actually face, signed by the partner who holds the view, and identified as judgment.

For journalists and researchers

Everything here is reusable with attribution.

No form, no embargo, no approval step. Every figure we publish carries its source, its period, its basis and its limitations, and where we could not verify a widely repeated statistic we say so and publish the trace instead. If a number here is wrong, we would rather hear it from you than not.

Who to ask

Named contact
Travis Callahan, founding partner – travis@b2bcapital.ch
Response
Within 24 hours, including to say we do not know.
On the record
By default. We will tell you if something has to be background, and why.

How to cite us

Attribution line
“B2B Capital, M&A advisers, date of publication” – with a link to the page carrying the method.
Licence
Quote, excerpt and reproduce our charts with attribution. No permission required.
Corrections
Published in place, dated, with the previous version noted rather than removed.

What we will not give you

Client names
Ever, without written client consent.
A number we cannot source
Including several the industry repeats daily. Ask and we will show you the trace.
A comment on a live process
Ours or anyone else’s.
  • The Evidence Standard

    How we know what we know – every external claim this firm makes carries a provenance, and this is the published system.

    Read the standard →

  • Strategic Value Dispersion

    The concept our research programme is built to measure – stated precisely, with what the evidence does and does not establish.

    Read the concept →

  • Research Note 01: Indicative Bid Dispersion in European Technology M&A

    Publishes when the sample supports it, and not before. That restraint is the Evidence Standard at work.

    Forthcoming – sample definition, normalization method, and limitations stated

The research letter. New research and letters, when they exist – typically several times a year, never weekly, nothing else. You subscribe by e-mail and you leave by e-mail: one line, honoured the same day, no sequence to escape.

Research · The Evidence Standard

How we know what we know

Every external claim this firm makes carries a provenance. This page is the system – published, because an evidence standard you can't inspect is just an adjective.

The five tiers

Every number carries its source. Every source carries its tier.

E1Primary record – audited accounts, signed agreements, court and regulatory filings, our own mandate registers.
E2Independent analysis – peer-reviewed or large-sample studies, official statistics, named professional surveys with method disclosed.
E3Attributed practitioner data – law-firm and adviser studies, industry bodies, named firms’ published figures.
E4Management representation – what a company or a person told us, labelled as such until verified.
E5Inference – our own reasoning from E1–E4, always marked “inferred” or “to validate”.

Firm standard Every number on this site and in every document we produce carries one of these five tiers. No tier, no publication.


What this page does

Every material figure on this site tells you three things.

Where it came fromA source you can open, or our own records, named as such.
What it measuresThe population, the period and the rule for what counts.
What it does not proveThe inference it will not carry – stated beside it, not buried.

Three things follow. Market data is never presented as our data. Prior-career transactions are never presented as our mandates. An association is never quietly turned into a cause.

The numbers you will see most often

Our own figures, as defined – and where each one matters.

Five figures on this site are counted from our own mandates; the team’s prior-career figures are attributed where they appear. Each of the five is defined here once, in the terms it is counted in; the denominators are available on request.

34
Companies sold as sell-side adviser since 1 January 2020 – signed and completed, funds transferred. Not mandates, not letters of intent. As of September 2026.
86%
Of the letters of intent our clients have signed since 2020, the share that reached completion.
76%
Of the earn-outs our clients have agreed since 2020, the share paid in full at final settlement.
32%
Average final price above the valuation expectation each founder documented with us at signing, across completed mandates.
67 hours
Founder time across a whole mandate – the counted average across every completed mandate since 2020, from our own time records.

Published 2 September 2026 · Revised when a cited source updates, and at least annually · Sources are in the chapters, where each figure carries its limits.

How every other claim is classified

Two axes, not one ladder.

Every substantive claim we publish is classifiable on two independent dimensions – because a perfect source can still be used to make a bad inference, and our own observations can be accurate but statistically young.

AxisLevels
Source basis S1 – audited, contractual, official or primary documents · S2 – reputable published datasets and peer-reviewed research, with transparent method, cited with their limitations · S3 – practitioner and commercial evidence, attributed · S4 – our own internal observation or management representation, labelled as such
Claim type O – observed fact · R – relationship (things that move together, without a causal claim) · C – causal claim (held to the highest bar, and rare in our work) · I – inference or judgment, marked as ours · X – illustration, labelled illustrative

A published finding might be S2/R: a credible external dataset, making a relationship claim. A process observation might be S4/O: our own data, an observed fact, with its basis stated and the full method available on request. What you will not find is a causal claim standing on an S4 source.

  • Attribution classes.

    Every proof point states whose it is: a firm transaction, a partner's prior-career work, a team aggregate, a client's outcome, or market data. The categories are never blended. When you read "our senior team has closed more than $40 billion of transactions," the attribution is stated in the same sentence – deliberately, and permanently.

  • Sample honesty.

    Our own transaction sample is young and growing. Every figure drawn from it names its population and its eligibility rule; the denominator is available on request. No finding is generalised beyond what the sample carries, and none of these figures is a prediction for an individual mandate. A small honest dataset beats a large implied one.

  • Corrections and versions.

    Published pieces carry publication and revision dates. Material corrections are noted in the piece, not silently overwritten. Methodology changes are announced, not smuggled.

  • What this costs us.

    Sometimes the evidence supports a narrower claim than the market would prefer to hear. We publish the narrower claim.

A career figure, in full

The ABB acquisition programme, 2010–2014

The People page says Travis Callahan worked inside a corporate acquisition programme that took in forty-one businesses in five years, and names four of them. This is the whole list, so the claim can be checked rather than taken. It is ABB’s record, not B2B Capital’s: he was one of the lawyers negotiating and structuring inside it, as Group Vice President for M&A and Venture Capital (Senior Legal Counsel), not its chief executive, and no transaction below is presented as a mandate of this firm.

Thirty-three transactions were announced at group level in the window: twenty-two acquisitions of control, five divestitures, five minority or stake-increase investments, and one bid that lapsed. Fourteen disclosed a figure; nineteen did not, and are shown as undisclosed rather than estimated. ABB’s audited accounts record forty-one acquired businesses across the same five years – so roughly nineteen were small bolt-ons the group never announced separately. Cash spent on acquisitions, net of cash acquired, was $1,275M (2010), $3,805M (2011), $3,643M (2012), $897M (2013) and $58M (2014).

AnnouncedTarget or businessCountryTypeConsideration
15 Feb 2010Jokab Safety International ABSwedenAcquisitionUndisclosed
29 Mar 2010Semiconductor business of Polovodiče a.s.Czech RepublicAcquisitionUndisclosed
5 May 2010VentyxUSAAcquisitionMore than $1B (purchase price)
17 May 2010ABB Limited (India), 52.11% → 75%IndiaStake increase≈ $965M (Rs 900/share)
3 Jun 2010K-TEKUSAAcquisitionUndisclosed
8 Jun 2010Chloride Group PLCUKBid lapsed≈ £860M – bid lapsed, never completed
24 Nov 2010Aquamarine PowerUK / ScotlandMinority / stake increase≈ $13 m investment
30 Nov 2010Baldor Electric CompanyUSAAcquisition$4.2B enterprise value ($63.50/share)
10 Jan 2011ECOtality Inc.USAMinority / stake increase$10 m investment
16 Mar 2011Novatec SolarGermanyMinority / stake increaseUndisclosed
9 May 2011MincomAustraliaAcquisitionUndisclosed
12 May 2011Validus DC SystemsUSAAcquisitionUndisclosed
1 Jul 2011Epyon B.V.NetherlandsAcquisitionUndisclosed
4 Jul 2011Lorentzen & WettreSwedenAcquisitionSEK 750M / $119M
11 Jul 2011Trasfor GroupSwitzerland + ItalyAcquisitionUndisclosed
15 Nov 2011Powercorp Pty LtdAustraliaAcquisitionUndisclosed
28 Nov 2011Envitech Energy Inc.CanadaAcquisitionUndisclosed
12 Dec 2011Newave Energy Holding SASwitzerlandAcquisition≈ CHF 170M (CHF 56.00/share)
14 Dec 2011GreenVolts Inc.USAMinority / stake increase≈ $20 m of a $35 m round
30 Jan 2012Thomas & Betts CorporationUSAAcquisition≈ $3.9B ($72.00/share)
1–4 Jun 2012Tropos Networks Inc.USAAcquisitionUndisclosed
22 Apr 2013Power-One, Inc.USAAcquisition≈ $1.0B equity value ($6.35/share)
2 May 2013Los Gatos ResearchUSAAcquisitionUndisclosed
7 Jun 2013Dynamotive LtdUKAcquisitionUndisclosed
30 Jul 2013Alstom's ring motor businessSpainAcquisitionUndisclosed
5 Aug 2013Newron System S.A.FranceAcquisitionUndisclosed
6 Sep 2013ELBI ElektrikTurkeyAcquisitionUndisclosed
8 Oct 2013Baldor's generator-set businessUSADivestitureUndisclosed
21 Mar 2014Thomas & Betts HVAC businessUSADivestiture$260M, all cash
28 Apr 2014Power-One Power Solutions businessUSA + internationalDivestiture≈ $117M
27 Jun 2014Meyer Steel Structures (Thomas & Betts)USADivestiture$600M, all cash
25 Jul 2014Spirit ITNetherlandsAcquisitionUndisclosed
20 Aug 2014ABB Full Service businessGlobalDivestitureUndisclosed

Do not add these figures together. Baldor’s $4.2B is an enterprise value including about $1.1B of net debt; Thomas & Betts’ $3.9B was the anticipated cash outflow at announcement; Power-One’s $1.0B is an equity value, against an actual cash outflow of $737M. Non-dollar figures are left in their original currency, unconverted. The Chloride bid lapsed on 1 July 2010 and belongs in no total. Sources: ABB group press releases, ABB Group Annual Reports 2010–2014 (Note 3), and counterparty announcements; the working file with a source URL per row is held internally and available on request.

Published 2 September 2026 · Revised when a cited source updates, and at least annually · Sources are in the chapters, where each figure carries its limits.

Hold us to it.

Ask for the denominator behind any number on this site, or a reference call with a founder we sold for. We would rather lose a mandate than win it with a figure we cannot stand behind.